Cargando…

A serial 3- and 9-year optical coherence tomography assessment of vascular healing response to sirolimus- and paclitaxel-eluting stents

Early-generation drug-eluting stents (DES) have been demonstrated to delay vascular healing. Limited optical coherence tomography (OCT) data on the very long-term neointimal response after DES implantation are available. The aim of this study was a serial OCT assessment of neointimal thickness, sten...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tomaniak, Mariusz, Kołtowski, Łukasz, Pietrasik, Arkadiusz, Rdzanek, Adam, Jąkała, Jacek, Proniewska, Klaudia, Malinowski, Krzysztof, Mazurek, Tomasz, Filipiak, Krzysztof J., Brugaletta, Salvatore, Opolski, Grzegorz, Kochman, Janusz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2018
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373305/ https://www.ncbi.nlm.nih.gov/pubmed/30168010 http://dx.doi.org/10.1007/s10554-018-1437-7

Ejemplares similares

OCT-Derived Plaque Morphology and FFR-Determined Hemodynamic Relevance in Intermediate Coronary Stenoses
por: Tomaniak, Mariusz, et al.
Publicado: (2021)

Delayed neointimal healing pattern after bioresorbable scaffold implantation
por: Ochijewicz, D., et al.
Publicado: (2018)

Treatment of severe tricuspid regurgitation with placement of percutaneous edge-to-edge posteroseptal and anteroseptal leaflet clips
por: Rdzanek, Adam, et al.
Publicado: (2019)

Inflammation as a determinant of healing response after coronary stent implantation
por: Ochijewicz, Dorota, et al.
Publicado: (2021)

Quantitative flow ratio and fractional flow reserve mismatch – clinical and biochemical predictors of measurement discrepancy
por: Zaleska, Martyna, et al.
Publicado: (2019)

Multimodality OCT, IVUS and FFR evaluation of coronary intermediate grade lesions in women vs. men
por: Baruś, Piotr, et al.
Publicado: (2023)

Immature platelet fraction in cardiovascular diagnostics and antiplatelet therapy monitoring
por: Gumiężna, Karolina, et al.
Publicado: (2023)

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
por: Ouyang, Hang, et al.
Publicado: (2021)

Comparisons of the Effects of Stent Eccentricity on the Neointimal Hyperplasia between Sirolimus-Eluting Stent versus Paclitaxel-Eluting Stent
por: Kim, Byeong-Keuk, et al.
Publicado: (2010)

Optimal Management of Patients with Severe Coronary Artery Disease Following Multidisciplinary Heart Team Approach—Insights from Tertiary Cardiovascular Care Center
por: Jonik, Szymon, et al.
Publicado: (2022)

Two-year Clinical Outcomes of Patients with Long Segments Drug-Eluting Stents: Comparison of Sirolimus-Eluting Stent with Paclitaxel-Eluting Stent
por: Kim, Ung, et al.
Publicado: (2011)

Increased risk of minor bleeding and antiplatelet therapy cessation in patients with acute coronary syndromes and low on-aspirin platelet reactivity. A prospective cohort study
por: Huczek, Zenon, et al.
Publicado: (2012)

Successful percutaneous coronary intervention after transcatheter aortic valve implantation with CoreValve bioprosthesis
por: Huczek, Zenon, et al.
Publicado: (2016)

Prosthetic valve endocarditis after transcatheter CoreValve Evolut R bioprosthesis implantation
por: Zbroński, Karol, et al.
Publicado: (2016)

Transcatheter mitral valve-in-valve implantation using a transseptal approach
por: Huczek, Zenon, et al.
Publicado: (2019)

Comparison of Sirolimus and Paclitaxel-Eluting Stents for Complex Coronary Lesions: An Intravascular Ultrasound Study
por: Cho, Yun-Kyeong, et al.
Publicado: (2009)

Health-related Quality of Life Increases After First-time Acute Myocardial Infarction: a Population-based Study
por: Gąsecka, Aleksandra, et al.
Publicado: (2022)

Everolimus-eluting stents versus sirolimus-eluting stents in patients with cardiac allograft vasculopathy
por: Hawranek, Michał, et al.
Publicado: (2021)

Safety and efficacy of biodegradable polymer-coated thin strut sirolimus-eluting stent vs. durable polymer-coated everolimus-eluting stent in patients with acute myocardial infarction
por: Gąsior, Paweł, et al.
Publicado: (2018)

Sirolimus-eluting coronary stents: a review
por: Abizaid, Alexandre
Publicado: (2007)

Biodegradable polymer-coated thin strut sirolimus-eluting stent versus durable polymer-coated everolimus-eluting stent in the diabetic population
por: Gasior, Pawel, et al.
Publicado: (2021)

Neoatherosclerosis in Sirolimus-Eluting Stents After Paclitaxel-Coated Ballooning Cannot Be Stabilized Despite PCSK9 Inhibitor Therapy
por: Miyoshi, Toru, et al.
Publicado: (2019)

Head-to-Head Comparison of Sirolimus-Eluting Stents versus Paclitaxel-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of 76 Studies
por: Zhang, Xinlin, et al.
Publicado: (2014)

Left ventricular remodelling pattern and its relation to clinical outcomes in patients with severe aortic stenosis treated with transcatheter aortic valve implantation
por: Rymuza, Bartosz, et al.
Publicado: (2017)

Direct transcatheter aortic valve implantation – one-year outcome of a case control study
por: Kochman, Janusz, et al.
Publicado: (2014)

Guided de-escalation of DAPT in acute coronary syndrome patients undergoing percutaneous coronary intervention with BVS implantation: a post-hoc analysis from the randomized TROPICAL-ACS trial
por: Koltowski, Lukasz, et al.
Publicado: (2019)

Long-Term Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Stents in Patients With Acute Myocardial Infarction: Four-Year Observational Study
por: Min, Gye-Sik, et al.
Publicado: (2012)

Soluble ST2 as a Biomarker for Early Complications in Patients with Chronic Thromboembolic Pulmonary Hypertension Treated with Balloon Pulmonary Angioplasty
por: Banaszkiewicz, Marta, et al.
Publicado: (2021)

Clinical experience with 12-month follow-up in patients after implantation of a novel long-tapered sirolimus drug-eluting stent
por: Podolec, Jakub, et al.
Publicado: (2019)

Late Thrombosis of Sirolimus-Eluting Stent: A Multifactorial Problem
por: Kranjec, Igor, et al.
Publicado: (2009)

Long-term effectiveness and safety of sirolimus drug-eluting stents
por: Bikkina, Mahesh, et al.
Publicado: (2011)

Impact of diabetes on clinical outcomes after revascularization with the dual therapy CD34 antibody‐covered sirolimus‐eluting Combo stent and the sirolimus‐eluting Orsiro stent
por: Jakobsen, Lars, et al.
Publicado: (2022)

OCULUS study: Virtual reality-based education in daily clinical practice
por: Balsam, Paweł, et al.
Publicado: (2019)

Percutaneous removal of a catheter fragment from the right atrium
por: Pietrasik, Arkadiusz, et al.
Publicado: (2021)

Mechanical circulatory support for high-risk percutaneous coronary interventions and cardiogenic shock: Rationale and design of the multicenter, investigator-initiated IMPELLA-PL registry
por: Pietrasik, Arkadiusz, et al.
Publicado: (2022)

Role of P2Y Receptors in Platelet Extracellular Vesicle Release
por: Gąsecka, Aleksandra, et al.
Publicado: (2020)

Acute lower limb ischemia following Angio-Seal deployment after transfemoral percutaneous coronary intervention
por: Walczewski, Michał, et al.
Publicado: (2019)

Drug eluting stents: Focus on Cypher™ sirolimus-eluting coronary stents in the treatment of patients with bifurcation lesions
por: Chieffo, Alaide, et al.
Publicado: (2007)

Two-Year Results of an Open-Label Randomized Comparison of Everolimus-Eluting Stents and Sirolimus-Eluting Stents
por: Velders, Matthijs A., et al.
Publicado: (2013)

Clinical results of everolimus-eluting stents and sirolimus-eluting stents in patients undergoing percutaneous coronary intervention
por: Jafaripour, Iraj, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rqb9lfm028abjhpeu9b05nmfu8